Westermann, Frank

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

Khan, J., Wei, J. S., Ringnér, M., Saal, L. H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C. R., Peterson, C., et al. (2001) · Nature Medicine

Gene expression and cancer classificationBreast Cancer Treatment Studies

Cited by 2,644

The landscape of genomic alterations across childhood cancers

ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature

Cancer Genomics and DiagnosticsChromatin Remodeling and Cancer

Cited by 1,572

A novel and universal method for microRNA RT-qPCR data normalization

Mestdagh, P., Van Vlierberghe, P., De Weer, A., Muth, D., Westermann, F., Speleman, F., & Vandesompele, J. (2009) · Genome Biology

Molecular Biology Techniques and ApplicationsMicroRNA in disease regulation

Cited by 1,079

Histone deacetylase 8 in neuroblastoma tumorigenesis

Oehme, I., Deubzer, H. E., Wegener, D., Pickert, D., Linke, J.-P., Hero, B., Kopp-Schneider, A., Westermann, F., Ulrich, S. M., von Deimling, A., et al. (2009) · Clinical Cancer Research

Neuroblastoma Research and TreatmentsHistone Deacetylase Inhibitors Research

Cited by 398

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification

Oberthuer, A., Berthold, F., Warnat, P., Hero, B., Kahlert, Y., Spitz, R., Ernestus, K., König, R., Haas, S., Eils, R., et al. (2006) · Journal of Clinical Oncology

Neuroblastoma Research and TreatmentsGene expression and cancer classification

Cited by 291

Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma

Oberthuer, A., Hero, B., Berthold, F., Juraeva, D., Faldum, A., Kahlert, Y., Asgharzadeh, S., Seeger, R., Scaruffi, P., Tonini, G. P., et al. (2010) · Journal of Clinical Oncology

Neuroblastoma Research and TreatmentsBreast Cancer Treatment Studies

Cited by 135

Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer

Dieter, S. M., Siegl, C., Codó, P. L., Huerta, M., Ostermann-Parucha, A. L., Schulz, E., Zowada, M. K., Martin, S., Laaber, K., Nowrouzi, A., et al. (2021) · Cell Reports

Protein Degradation and InhibitorsColorectal Cancer Treatments and Studies

Cited by 95

MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma

Zhang, S., Wei, J. S., Li, S. Q., Badgett, T. C., Song, Y. K., Agarwal, S., Coarfa, C., Tolman, C., Hurd, L., Liao, H., et al. (2016) · Cancer Letters

Neuroblastoma Research and TreatmentsRNA Research and Splicing

Cited by 58